Israel - English - Ministry of Health

rafa laboratories ltd - mesalazine - enema - mesalazine 1 g - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

Israel - English - Ministry of Health

merck sharp & dohme israel ltd - desogestrel; ethinylestradiol - tablets - desogestrel 150 mcg; ethinylestradiol 20 mcg - desogestrel - desogestrel - oral contraception

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - coated tablets - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Israel - English - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - film coated tablets - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting .• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - antihemophilic factor (recombinant) sucrose formulated - injection, powder, lyophilized, for solution - 1000 iu/vial - antihemophilic factor (recombinant) sucrose formulated 1000 iu/vial

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - antihemophilic factor (recombinant) sucrose formulated - injection, powder, lyophilized, for solution - 250iu/vial - antihemophilic factor (recombinant) sucrose formulated 250iu/vial

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - antihemophilic factor (recombinant) sucrose formulated - injection, powder, lyophilized, for solution - 500iu/vial - antihemophilic factor (recombinant) sucrose formulated 500iu/vial

Philippines - English - FDA (Food And Drug Administration)

weisser chemical industries - ammonium carbonate , strong ammonia (aromatic spirit of ammoniia) - solution, topical - 3.4g + 3.6ml / 100ml

Philippines - English - FDA (Food And Drug Administration)

roz laboratories inc - ammonium carbonate , strong ammonia solution (aromatic spirit of ammonia) - solution, topical - 3.4g + 3.6g / 100ml

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow pty ltd - bromoxynil as the octanoate ester; mcpa present as the 2-ethyl hexyl ester; aromatic hydrocarbon - other liquids to be applied undiluted - bromoxynil as the octanoate ester nitrile active 12.0 g/l; mcpa present as the 2-ethyl hexyl ester phenoxy acids-mcpa-ester active 12.0 g/l; aromatic hydrocarbon solvent other 20.0 g/l - herbicide